Publications in medicine and public health, 2013 to 2025

Before my doctoral work, I trained as a physician (MD, MPH) and worked as a health-systems researcher. Most of this earlier record concerns the economics, quality, and measurement of care, with a second line in epidemiology and clinical medicine.

Google Scholar (October 2026): 849 citations, h-index 19, i10-index 23 (full profile). Lead, co-first, and corresponding-author roles are noted; all others are co-authored. Impact factors: JCR 2025 (Clarivate, June 2026).

Health systems: the cost, quality, and measurement of care

Health-services research on the economics of care, disparities in access, and the instruments used to measure it. This is the thread closest to my current work on organizations.

The economic burden of malignant brain tumors
Khanmohammadi S, Mobarakabadi M, Mohebi F
Corresponding author, Human Brain and Spinal Cord Tumors (book chapter), 2023, Cited by 36

Quality and cost of healthcare services for patients with diabetes in Iran: a nationwide short-term longitudinal survey
Abbasi-Kangevari M, Mohebi F, Ghamari SH, Modirian M, Shahbal N, Ahmadi N, et al.
Co-first author, Frontiers in Endocrinology, IF 5.7, 2023, Cited by 10

Patient experience with chronic obstructive pulmonary disease: a nationally representative study of the quality and cost of care
Ghamari SH, Mohebi F, Abbasi-Kangevari M, Peiman S, Rahimi B, et al.
Frontiers in Public Health, IF 4.1, 2023, Cited by 7

The incremental cost of implementing the WHO Package of Essential Noncommunicable (PEN) disease interventions in Iran
Azmin M, Mohebi F, Yoosefi M, Ahmadi N, Shirazi S, Modirian M, Farzadfar F
Co-first author, PLOS Global Public Health, IF 2.8, 2023, Cited by 6

Editorial: Disparities in cancer prevention and epidemiology
Montazeri F, Komaki H, Mohebi F, Mohajer B, Mansournia MA, Shahraz S, Farzadfar F
Corresponding author, Frontiers in Oncology, IF 3.4, 2022, Cited by 3

Editorial: Disparities in mental health
Merati M, Komaki H, Mohebi F, Kabir H, Haack LM
Corresponding author, Frontiers in Psychiatry, IF 3.8, 2024, Cited by 4

Measurement and instruments

The Duke University Religion Index (DUREL): validation and reliability of the Farsi version
Hafizi S, Memari AH, Pakrah M, Mohebi F, Saghazadeh A, Koenig HG
Psychological Reports, IF 1.9, 2013, Cited by 60

The impact of response shift on reporting patient-reported-outcome change over time in randomized trials: a systematic review
Shahraz S, Mohebi F, Khanmohammadi S, Nolte S
Value in Health, IF 6.2, 2021, Cited by 1

Outcomes and technology in cancer care

Quality of life in patients with meningioma
Merati M, Montazeri F, Mohebi F, Kabir H, Komaki H
IntechOpen (book chapter), 2024, Cited by 1

MPH thesis

Measuring supplier-induced demand: physicians as an informed-consumer control
MPH thesis, Tehran University of Medical Sciences, Unpublished

Epidemiology and the burden of disease

National and subnational estimation of risk factors, injuries, and chronic diseases including multiple sclerosis and cancers.

Physical activity profile of the Iranian population: STEPS survey, 2016
Mohebi F, Mohajer B, Yoosefi M, Sheidaei A, Zokaei H, Damerchilu B, et al.
Lead author, BMC Public Health, IF 3.5, 2019, Cited by 124

Trends of national and subnational incidence of childhood cancer groups in Iran, 1990–2016
Shabani M, Saeedi Moghaddam S, Ataeinia B, Rezaei N, Mohebi F, et al.
Frontiers in Oncology, IF 3.4, 2020, Cited by 33

The level and trend of road-traffic-injury mortality in Iran, 1990–2015: a story of successful regulation and a roadmap for future policy
Shams M, Mohebi F, Gohari K, Masinaei M, Mohajer B, Rezaei N, et al.
Co-first author, BMC Public Health, IF 3.5, 2021, Cited by 32

National and subnational trends in incidence and mortality of lung cancer in Iran, 1990–2016
Rajai N, Ghanbari A, Yoosefi M, Mohebi F, Mohajer B, Sheidaei A, et al.
Asia-Pacific Journal of Clinical Oncology, IF 2.1, 2020, Cited by 25

A national and subnational metaregression of insufficient physical activity among Iranian adults, 2001–2016
Kamalian A, Khosravi Shadmani F, Yoosefi M, Mohajer B, Mohebi F, et al.
Scientific Reports, IF 4.9, 2021, Cited by 22

The epidemiologic aspects of the COVID-19 outbreak: spreading beyond expectations
Hanaei S, Mohebi F, Moradi-Lakeh M, Jabbari P, Mehta SK, Kryvenko LS, et al.
Coronavirus Disease — COVID-19 (book chapter), 2021, Cited by 6

Level and trend of total plasma cholesterol at national and subnational scale in Iran, 1990–2016: an age–spatio-temporal analysis
Mehdipour P, Mohammadi E, Sepanlou SG, Ahmadvand A, Peykari N, Djalalinia S, … Mohebi F, et al.
Journal of Diabetes & Metabolic Disorders, IF 2.1, 2022, Cited by 5

Validation of the self-reported diagnosis of diabetes, hypercholesterolemia, and hypertension in Iran: STEPS 2016
Merati M, Mohebi F, Alipour E, Masinaei M, Pooyan A, Mehdipour P, et al.
Journal of Diabetes & Metabolic Disorders, IF 2.1, 2024, Cited by 6

Multiple sclerosis

Multiple sclerosis national registry system in Iran: validity and reliability of a minimum data set
Shahin S, Eskandarieh S, Moghadasi AN, Razazian N, Baghbanian SM, Ashtari F, … Mohebi F, et al.
Multiple Sclerosis and Related Disorders, IF 3.0, 2019, Cited by 51

HLA-DRB1 polymorphism and susceptibility to multiple sclerosis in the MENA region: a systematic review and meta-analysis
Mohajer B, Abbasi N, Pishgar F, Abdolalizadeh A, Ebrahimi H, Razaviyoun T, Mohebi F, et al.
Journal of Neuroimmunology, IF 3.1, 2018, Cited by 22

Burden of multiple sclerosis in Iran, 1990–2017
Fattahi N, Saeedi Moghaddam S, Mohebi F, Rezaei N, Masinaei M, et al.
BMC Neurology, IF 2.6, 2021, Cited by 16

Prevalence and incidence of multiple sclerosis in Ardabil, northwest Iran
Molazadeh N, Mohebi F, Altafi D, Sahraian MA
Multiple Sclerosis and Related Disorders, IF 3.0, 2021, Cited by 14

Clinical medicine: dermatology and neuroimaging

Clinical and mechanistic studies in skin disease and the brain.

Dermatology

Autoimmune Bullous Disease Quality-of-Life (ABQoL) questionnaire: validation of the Persian version in pemphigus vulgaris
Teimourpour A, Hedayat K, Salarvand F, Ghandi N, Ghiasi M, Mahmoudi H, … Mohebi F, et al.
International Journal of Women's Dermatology, IF 3, 2020, Cited by 21

Estimated cut-off values for pemphigus severity classification by PDAI, ABSIS, and PDAUS
Mohebi F, Tavakolpour S, Teimourpour A, Toosi R, Mahmoudi H, Balighi K, et al.
Lead author, BMC Dermatology, IF 3.1, 2020, Cited by 17

Association between acantholysis and anti-desmoglein 1 and 3 values in pemphigus vulgaris and foliaceus
Mobarakabadi M, Rajai N, Kamyab K, Balighi K, Mahmoudi H, Tavakolpour S, … Mohebi F, et al.
Journal of Cutaneous Immunology and Allergy, 2019, Cited by 5

Neuroimaging

Structural white-matter alterations as compensatory mechanisms in Parkinson's disease: a systematic review of DTI studies
Sanjari Moghaddam H, Dolatshahi M, Mohebi F, Aarabi MH
Journal of Neuroscience Research, IF 3.1, 2020, Cited by 51

White-matter microstructural abnormalities in primary insomnia: a systematic review of DTI studies
Sanjari Moghaddam H, Mohammadi E, Dolatshahi M, Mohebi F, Ashrafi A, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry, IF 4.2, 2021, Cited by 38

Microstructural white-matter alterations and personality traits: a diffusion-MRI study
Sanjari Moghaddam H, Mehrabinejad MM, Mohebi F, Hajighadery A, Maroufi SF, et al.
Journal of Research in Personality, IF 3.4, 2020, Cited by 12

Does gadolinium deposition lead to metabolite alteration in the dentate nucleus? An MRS study in patients with MS
Mohammadzadeh M, Kolahi S, Mehrabi Nejad MM, Firouznia K, Naghibi H, Mohammadzadeh A, … Mohebi F, et al.
American Journal of Neuroradiology, IF 3.5, 2022, Cited by 2